Les nanotechnologies peuvent-elles contribuer à traiter des maladies sévères ? / (notice nᵒ 3623)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03116 a2200337 4500 |
| 001 - CONTROL NUMBER | |
| control field | OB-cdf-191 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | FrMaCLE |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20251214082607.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cu ||||||m|||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 130123e||||||||xx |||||s|||||||||0|fr|d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-2-7226-0098-0 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.4000/books.cdf.191 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | FR-FrMaCLE |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fra |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Couvreur, Patrick |
| 245 14 - TITLE STATEMENT | |
| Title | Les nanotechnologies peuvent-elles contribuer à traiter des maladies sévères ? / |
| Statement of responsibility, etc. | Patrick Couvreur. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Paris : |
| Name of publisher, distributor, etc. | Collège de France, |
| Date of publication, distribution, etc. | 2013. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 60 p. |
| 500 ## - GENERAL NOTE | |
| General note | Ebook |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Leçon inaugurale prononcée le 21 janvier 2010 Chaire d’Innovation Technologique Liliane Bettencourt (2009-2010) La conception de nanotechnologies capables de transporter les médicaments dans l’organisme et de les libérer de manière spécifique au niveau du site d’action permet d’augmenter l’activité thérapeutique et de réduire la toxicité de nombreux médicaments. Ces « nanovecteurs » sont capables de protéger la molécule active de la dégradation par les enzymes de l’organisme, de l’adresser sélectivement vers le tissu ou la cellule cible, et d’en contrôler la libération. Plus spécifiques que les formulations pharmaceutiques traditionnelles, les « nanomédicaments » permettent de concevoir de nouvelles stratégies thérapeutiques dans la lutte contre des maladies sévères : cancers, infections intracellulaires, maladies métaboliques ou neurodégénératives, etc. La chaire d’Innovation technologique du Collège de France a été créée avec le soutien de la Fondation Bettencourt-Schueller. Inaugural lecture given on January 21st 2010 Chair in Technological Innovation - Liliane Bettencourt (2009-2010) The design of nanotechnologies able to transport medicines within our organisms and release them at the specific location in the body required for optimum effect is a means of increasing therapeutic activity and reducing the toxicity of numerous medicines. These “nanovectors” protect active molecules from being broken down by the body’s enzymes, ensure they are selectively directed to the target tissue or cell(s) and control their release. These “nanodrugs” are more specific than traditional pharmaceutical formulations and enable scientists to develop new therapeutic strategies in the fight against serious illness such as cancer, intracellular infections, metabolic or neurodegenerative diseases and so forth. The Collège de France Chair in Technological Innovation was created with the support of the Bettencourt-Schueller Foundation. |
| 540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE | |
| Terms governing use and reproduction | OpenEdition Books License |
| Uniform Resource Identifier | <a href="https://www.openedition.org/12554">https://www.openedition.org/12554</a> |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Social Sciences, Biomedical |
| Topical term or geographic name entry element | médecine |
| Topical term or geographic name entry element | nanomédicament |
| Topical term or geographic name entry element | nanotechnologies |
| Topical term or geographic name entry element | pharmacotechnie |
| Topical term or geographic name entry element | innovation technologique |
| 760 0# - MAIN SERIES ENTRY | |
| International Standard Serial Number | 2109-9235 |
| 776 ## - ADDITIONAL PHYSICAL FORM ENTRY | |
| International Standard Book Number | 978-2-213-65492-8 |
| 856 4# - ELECTRONIC LOCATION AND ACCESS | |
| Data provenance | Couvreur, Patrick |
| Uniform Resource Identifier | <a href="https://books.openedition.org/cdf/191">https://books.openedition.org/cdf/191</a> |
| Link text | Les nanotechnologies peuvent-elles contribuer à traiter des maladies sévères ? |
Pas d'exemplaire disponible.
